Introduction {#Sec1}
============

In view of the gaining popularity of oral endosseous implants in general and specifically the extended use of implants in patients with head and neck cancer to give retention to a (partial) dental prosthesis, the issue of malignancies arising in the vicinity of dental implants will be encountered in the future more often \[[@CR1], [@CR2]\]. Primary oral squamous cell carcinomas (OSCC), recurrences, or even second primary tumors may arise in the vicinity of already-functioning implants. Few reports have been published about this issue \[[@CR3]--[@CR13]\]. Sometimes, their initial clinical appearance suggested peri-implantitis \[[@CR4], [@CR7], [@CR13]\], thereby demonstrating that malignancies can masquerade as a benign peri-implant complication. It has to be emphasized that a high degree of vigilance is required. The majority of all presented cases had at least one recognized risk factor for oral cancer \[[@CR6]\], thereby stressing that the carcinogenic role of endosseous implants has never been established \[[@CR1]\]. Surgery with postoperative radiotherapy on indication is still the first choice of curative treatment for an OSCC.

Surprisingly, in the literature, the topic of the type of resection when dental implants are adjacent or around the tumor is only limitedly addressed. When no evident bone invasion is present, a simple technique of removing the tumor including the dental implants can be used.

Case report {#Sec2}
===========

A 65-year-old female, suffering from an OSCC of the right anterior floor of the mouth (pT~1~N~2b~M~0~), was treated in November 2002 with a wide excision in combination with a lateral neck dissection at the right side. To achieve radical removal, the lower teeth had to be extracted, and the alveolar process was reduced in height. Subsequently, two endosseous implants (TiUnite Mark III RP, Nobel Biocare®, Gothenburg, Sweden) were placed into the symphyseal region of the mandible to facilitate early prosthetic rehabilitation \[[@CR1], [@CR2]\].

Postoperatively, the patient was subjected to a fractionated radiotherapy schedule up to a cumulative dose of 64 Gy (32 times, receiving 2 Gy at each session) because of a spidery growth pattern and two ipsilateral positive lymph nodes of level Ib. After a healing period of 3 months postradiation, the patient desired prosthetic rehabilitation. Consecutively, healing abutments were placed (June 2002), and a bar-retained overdenture was fabricated. Since then, this construction functioned satisfactorily for about 4 years without further complications.

Unfortunately, in October 2006, 4 years postradiation, a recurrent OSCC (cT~2~N~0~M~0~) developed. Between the two implants, an exophytic tumor was observed in the floor of the mouth extending to the attached keratinized peri-implant mucosa of both implants (Fig. [1a](#Fig1){ref-type="fig"}). Radiographically (OPG and CT scan), no osteolytic lesions around the dental implants, indicative for bone invasion, could be observed \[[@CR14]\]. Fig. 1**a** The carcinoma is positioned between the *white arrows*. **b** First, an incision is made, respecting a border (see *arrows*) of 1 cm around the tumor. **c** Intraoral view after removing the upper bone segment. Clearly, the apical parts of both implants are visible, as also **d** the cervical parts in the block resection (see *arrows*)

To achieve radical removal, first, a tumor-free mucosal margin of 1 cm was outlined. Subsequently, the mandibular bone surface was exposed by careful elevation of the mucoperiosteum in caudal direction, thereby preserving the attachment of the soft tissue to the aimed cranial bone segment (Fig. [1b](#Fig1){ref-type="fig"}). Then, the marginal mandibulectomy was performed, utilizing a standard drill unit (Elan-EC, Aesculap®, Tuttlingen, Germany) connected to a saw using a standard saw blade (Braun-Aesculap® sterile blades, Ref GC615R; Tuttlingen, Germany). During the osteotomy, consecutively, the implants were also cut into two parts (Fig. [1c, d](#Fig1){ref-type="fig"}).

Postoperatively, the lower denture was not worn for 6 months. The mucosal defect was closed primarily. In addition, the patient was warned of the risk of fracture and instructed about oral hygiene and soft diet. The soft tissues healed well (Fig. [2](#Fig2){ref-type="fig"}). Fig. 2**a** Panoramic radiograph preoperatively showing both the implants with their interconnecting bar and **b** after resection. Notice the round edges of the osteotomy (*white arrows*). **c** Intraoral view 1 year after partial implant removal

Histology showed a radically removed tumor with an 8-mm free mucosal margin. The tumor had an infiltrative spidery-type growth pattern in the lamina propria. Fortunately, no bone, perineural, or intravascular invasion was observed.

Two years postoperatively (November 2008), it was decided to insert dental implants again. After exposing the mucoperiostal flap, the apical parts of the cut implants could be easily identified (Fig. [3](#Fig3){ref-type="fig"}). Three years after resection of the recurrent tumor and 1 year after reimplantation, the patient is disease free and has a good oral function. Fig. 3**a** Situation after placement of three implants. The cut implants (*white arrows*) can be easily identified. **b** Panoramic radiograph postoperatively showing both the new and the cut implants (*white arrows*)

Discussion {#Sec3}
==========

Only few previously reported cases of malignancies arising in the vicinity of dental implants have been published \[[@CR3]--[@CR13]\]. Definitely, this number will increase in the future due to two main reasons. Firstly, prosthetic rehabilitation using endosseous implants is gaining in popularity, implicating that, within the group developing an OSCC, more patients will show up with endosseous implants. Secondly, in patients suffering from intraoral carcinomas, there is more and more tendency to install endosseous implants to restore their oral functioning \[[@CR1], [@CR2]\]. The fact that tumor recurrences appear mainly in the first two postoperative years explains why the phenomenon of a "tumor around endosseous implants" will occur significantly more in the coming years.

Some authors discuss the topic of peri-implant carcinomas first presenting itself as peri-implantitis. They emphasize that, in patients with long-standing and recurring leukoplakia, heavy smoking, and alcohol abuse, a biopsy should be taken \[[@CR4], [@CR7], [@CR13]\]. Obviously, if the patient already has a history of malignancy, each oral lesion, including peri-implantitis, is a suspect for carcinoma.

A literature search yielded 11 previously documented cases of malignancy adjacent to implants \[[@CR3]--[@CR13]\]. No papers emphasize that osseointegrated implants have been clearly identified as a potential route of entry for OSCC into the mandible. However, one report illustrated an OSCC that occurred in relation to osseointegrated implants, showing the apparent invasion of the mandibular alveolus by tumor along the line of the implant fixture \[[@CR12]\].

To our knowledge, this is the first report that describes the removal of implants in the vicinity of an OSCC by cutting them consecutively during the marginal mandibulectomy. To remove an osseointegrated implant, alternatively, with round or hollow cylinder burrs, a gap could be prepared around the implant. From an oncological point of view, this approach is undesired with respect to tumor spill/spread. Moreover, removing an implant in total creates a gap in the mandibular bone, increasing significantly the risk of mandibular fractures. In case of a total mandibulectomy, an extensive reconstruction of the anterior mandible would be mandatory. Surprisingly, this sawing procedure was much easier than expected, thereby leaving the apical parts in the lower mandibular bone segment (Fig. [1d](#Fig1){ref-type="fig"}). The residual vertical mandibular height was 11 mm. It should be emphasized that sharp edges between the horizontal and vertical bone cuts have to be avoided, as these may lead to fractures \[[@CR15]\].

In case of an OSCC, traditional bone and soft margins for oncologic safety are 1.0 cm. In the anterior mandible, a marginal mandibulectomy is only indicated when there is sufficient height of the inferior border present. To limit the risk of pathologic fracture, at least a residual vertical bone height of 10 mm should be left. This method allows radical removal of the tumor, without the direct need of performing a more invasive segmental mandibulectomy. However, if radiographically bone resorption around the implants is observed, indicative for tumor invasion, a more radical surgical approach (e.g., segmental resection) is indicated.

**Open Access** This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

**Sponsors**

None

**Competing interests**

None declared

**Funding**

None

**Ethical approval**

Not required
